BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3317325)

  • 1. What's new in cancer monitoring?
    Matzku S
    Pathol Res Pract; 1987 Oct; 182(5):699-703. PubMed ID: 3317325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers as targets for selective diagnostic and therapeutic procedures.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
    Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
    Cazin JL; Gosselin P; Demaille A
    Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies: new agents for cancer detection and targeted therapy.
    Baldwin RW; Byers VS
    Cancer Detect Prev; 1991; 15(2):133-6. PubMed ID: 2032254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of monoclonal antibodies in the cytologic evaluation of tumors.
    Szpak C; McLendon RE; Simpson JF; Thor A; Johnston WW
    Clin Lab Med; 1990 Mar; 10(1):77-103. PubMed ID: 2184981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in the use of monoclonal antibodies for imaging and therapy.
    Monson JR
    Curr Opin Gen Surg; 1993; ():334-9. PubMed ID: 7584004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of immunoscintigraphy using monoclonal antibodies on the analysis of hormones and tumor markers. This is not the end of it!].
    Verheijen RH; Schijf CP
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1760. PubMed ID: 2797292
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer treatment--what's new?
    Sikora K; Thomas H
    Practitioner; 1988 Oct; 232(1456 ( Pt 2)):1146-50. PubMed ID: 3076955
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of monoclonal antibodies in the evaluation of the aggressiveness of tumors of the bladder].
    Ravery V; Popov Z; Bellot J; Abbou CC; Chopin DK
    Ann Urol (Paris); 1993; 27(1):45-50. PubMed ID: 8470880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.
    Bonner RB; Liebert M; Hurst RE; Grossman HB; Bane BL; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):971-8. PubMed ID: 8959319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers].
    Hattori N
    Gan No Rinsho; 1986 Aug; 32(10):1059-64. PubMed ID: 3537355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches to tumor detection and therapy using a combination of monoclonal antibody and cytokine.
    Greiner JW; Guadagni F; Roselli M; Nieroda CA
    Anticancer Res; 1996; 16(4B):2129-33. PubMed ID: 8694532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell markers in common cancers - therapeutic implications.
    Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
    Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in the diagnosis and therapy of malignant tumors: current status amd future perspectives].
    Obrist R
    Ther Umsch; 1988 Jun; 45(6):364-9. PubMed ID: 3413710
    [No Abstract]   [Full Text] [Related]  

  • 16. Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies.
    Rossi S; Laurino L; Furlanetto A; Chinellato S; Orvieto E; Canal F; Facchetti F; Dei Tos AP
    Am J Clin Pathol; 2005 Aug; 124(2):295-302. PubMed ID: 16040303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.
    Wong IH; Lo YM; Johnson PJ
    Ann N Y Acad Sci; 2001 Sep; 945():36-50. PubMed ID: 11708493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
    Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
    Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of markers in the histological diagnosis of tumors].
    Le Doussal V
    Pathol Biol (Paris); 1993 Jan; 41(1):33-4. PubMed ID: 8316460
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.
    Okamoto OK; Perez JF
    Expert Rev Mol Diagn; 2008 Jul; 8(4):387-93. PubMed ID: 18598221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.